An Open Label Study to Evaluate the Effect of Avastin in Association With Chemotherapy on Progression-Free Survival in Patients With Progressive Advanced/Metastatic Well-Differentiated Digestive Endocrine Tumors of the Gastrointestinal Tract.

Trial Profile

An Open Label Study to Evaluate the Effect of Avastin in Association With Chemotherapy on Progression-Free Survival in Patients With Progressive Advanced/Metastatic Well-Differentiated Digestive Endocrine Tumors of the Gastrointestinal Tract.

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Jan 2015

At a glance

  • Drugs Bevacizumab (Primary) ; Capecitabine; Fluorouracil; Streptozocin
  • Indications Gastrointestinal cancer; Pancreatic cancer
  • Focus Therapeutic Use
  • Acronyms BETTER
  • Sponsors Roche
  • Most Recent Events

    • 17 Jan 2012 Planned end date changed from 1 Apr 2012 to 1 May 2012 as reported by ClinicalTrials.gov.
    • 15 Oct 2010 Planned end date changed from 1 Oct 2011 to 1 Apr 2012 as reported by ClinicalTrials.gov.
    • 18 Nov 2009 Status changed from recruiting to active, no longer recruiting as reported by Roche record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top